Royalty Pharma Acquires Royalty Interest in Risdiplam From PTC Therapeutics
NEW YORK, July 20, 2020 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) announced today an agreement with PTC Therapeutics, […]
Rhythm Pharmaceuticals Announces Appointment of David Meeker, M.D., as Chief Executive Officer
BOSTON, July 20, 2020 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq:RYTM), a late-stage biopharmaceutical company aimed at developing and commercializing […]
ContraFect Announces up to $18.9 Million in Funding from CARB-X to Support Acceleration of the CF-370 Program for Treating Pseudomonas aeruginosa Infections towards Clinical Stage Development
YONKERS, N.Y., July 20, 2020 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and […]
Applied Materials Solves Major Bottleneck to Continued 2D Scaling
SANTA CLARA, Calif., July 20, 2020 (GLOBE NEWSWIRE) — Applied Materials, Inc. today introduced a new technology that removes a […]
China NMPA Accepts NDA Submission of Ripretinib for Advanced Gastrointestinal Stromal Tumor
China NMPA acceptance of NDA follows recent U.S. FDA approval for the treatment ofadult patients with advanced GIST who have […]
Anika To Launch Six FDA-Cleared Sports Medicine and Extremities Products in Third Quarter of 2020
BEDFORD, Mass., July 20, 2020 (GLOBE NEWSWIRE) — Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation, restoration and […]
U.S. Food and Drug Administration Accepts Karyopharm’s Supplemental New Drug Application for XPOVIO® (selinexor) as a Treatment for Patients with Multiple Myeloma After At Least One Prior Line of Therapy
NEWTON, Mass., July 20, 2020 (GLOBE NEWSWIRE) — Karyopharm Therapeutics Inc. (Nasdaq:KPTI), an innovation-driven pharmaceutical company, today announced that the […]
Lexicon Pharmaceuticals Announces Poster Presentations at the Virtual Cholangiocarcinoma Foundation Annual Conference
THE WOODLANDS, Texas, July 20, 2020 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today that four posters highlighting […]
Mesa Air Group Announces Third Quarter Fiscal Year 2020 Earnings Release and Conference Call Date
PHOENIX, July 20, 2020 (GLOBE NEWSWIRE) — Mesa Air Group, Inc. (NASDAQ: MESA) will release its third quarter earnings for fiscal year […]
BioXcel Therapeutics Announces Primary and Secondary Endpoints Met in Two Pivotal Phase 3 Trials of BXCL501 for the Acute Treatment of Agitation in Patients with Schizophrenia and Bipolar Disorder
Highly statistically significant improvements in PEC score observed vs. placebo (p<0.0001) at two hours in the SERENITY trials for both […]
